Polyamines Promote Cancer Growth via eIF5A2 Despite Anti-Aging Benefits

Overview

While spermidine, a polyamine, is known for its anti-aging effects through autophagy and mitochondrial support, new research reveals it can also enhance cancer cell proliferation by upregulating eIF5A2 and glycolytic metabolism. This dual role highlights a complex balance between longevity benefits and cancer risks.

Background

Polyamines such as spermidine have gained attention for their ability to stimulate autophagy and improve mitochondrial function, contributing to longevity. However, their role in cancer biology remains unclear. The translation factors eIF5A1 and eIF5A2, closely related proteins, appear to mediate distinct effects of polyamines in normal versus cancerous tissues. Understanding these mechanisms is critical for evaluating the safety of polyamine-based anti-aging interventions.

Data Highlights

Key Findings

• Polyamines increase glycolytic metabolism in cancer cells rather than enhancing mitochondrial respiration.
• Polyamines selectively promote translation of eIF5A2, not eIF5A1, in cancer cells, facilitating proliferation.
• miR-6514-5p normally suppresses eIF5A2 translation; polyamines disrupt this suppression.
• Silencing eIF5A2 significantly inhibits proliferation in cervical and breast cancer cell lines.
• Polyamines elevate ribosomal proteins linked to malignancy, such as RPS27A and RPL36A/L.
• eIF5A1 and eIF5A2 regulate distinct protein subsets, indicating different roles in normal versus cancer tissues.

Clinical Implications

These findings suggest caution when considering polyamine supplementation for anti-aging purposes, as they may inadvertently promote cancer cell growth via eIF5A2-mediated pathways. Targeting the eIF5A2-ribosome interaction could represent a novel therapeutic strategy for selective cancer treatment. Clinicians should weigh the potential oncogenic risks against longevity benefits in patients.

Conclusion

Polyamines exhibit a dual role by supporting mitochondrial function in normal cells while driving glycolysis and proliferation in cancer cells through eIF5A2. This mechanistic insight underscores the need for careful evaluation of polyamine-based interventions in clinical settings.

References

1. Higashi et al. 2024 -- Polyamines regulate eIF5A2 to promote cancer proliferation